Antidiabetic screening of commercial botanical products in 3T3-L1 adipocytes and db/db mice

Journal of Medicinal Food

Volumn 13, Issue 3, 2010, Pages 535-547

  Babish, John G ^a   Pacioretty, Linda M ^a   Bland, Jeffrey S ^b   Minich, Deanna M ^c   Hu, Jeffrey ^c   Tripp, Matthew L ^b  

^a Cornell Technology Park ^*  (United States)

^b MetaProteomics LLC   (United States)

^c Metagenics Inc   (United States)

Author keywords

3T3 L1 adipocytes; adipogenesis; adiponectin; anti inflammatory; db db mice; diabetes; metabolic syndrome

Indexed keywords

ACACIA NILOTICA EXTRACT; ADIPONECTIN; ANTIDIABETIC AGENT; CENTELLA ASIATICA EXTRACT; FENNEL OIL; INSULIN; METFORMIN; ROSIGLITAZONE; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN 3T3; CENTELLA ASIATICA; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG EFFICACY; FENNEL; GINSENG; GLUCOSE METABOLISM; GRAPE; HUMULUS LUPULUS; INSULIN BLOOD LEVEL; LIPOGENESIS; MOUSE; NONHUMAN; PHYLLANTHUS AMARUS VULGARIS; PLANT; POMEGRANATE; PRIORITY JOURNAL; WASABI;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FATTY ACIDS; INSULIN; MALE; MICE; MICE, OBESE; PLANT EXTRACTS; PLANTS; TUMOR NECROSIS FACTOR-ALPHA;

ACACIA NILOTICA; ALOE VERA; CENTELLA ASIATICA; EUTREMA WASABI; FOENICULUM VULGARE; HUMULUS LUPULUS; MOMORDICA CHARANTIA; MUS; PANAX QUINQUEFOLIUS; PHASEOLUS VULGARIS; PHYLLANTHUS AMARUS; PUNICA GRANATUM; VITIS VINIFERA;

EID: 77953757298     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.0110     Document Type: Article

References (49)

1. Aronson D: Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 2008;45:1-16.
2. Stumvoll M: Control of glycaemia: from molecules to men. Minkowski Lecture 2003. Diabetologia 2004;47:770-781.
3. Cowie CC, Rust KF, Byrd-Holt DD, et al.: Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-1268.
4. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
5. Yach D, Stuckler D, Brownell KD: Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006;12:62-66.
6. Boyle JP, Honeycutt AA, Narayan KM, et al.: Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001;24:1936-1940.
7. McCarty MF: Nutraceutical resources for diabetes prevention-an update. Med Hypotheses 2005;64:151-158.
8. Bailey CJ, Day C: Traditional plant medicines as treatments for diabetes. Diabetes Care 1989;12:553-564.
9. Ivorra MD, Paya M, Villar A: A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol 1989; 27:243-275.
10. Jia W, Gao W, Tang L: Antidiabetic herbal drugs officially approved in China. Phytother Res 2003;17:1127-1134.
11. Jung M, Park M, Lee HC, et al.: Antidiabetic agents from medicinal plants. Curr Med Chem 2006;13:1203-1218.
12. Wang HX, Ng TB: Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities. Life Sci 1999;65:2663-2677.
13. Swanston-Flatt SK, Day C, Flatt PR, Gould BJ, Bailey CJ: Glycaemic effects of traditional european plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res 1989;10:69-73. (Pubitemid 19228261)
14. Anderson DC Jr: Pharmacologic prevention or delay of type 2 diabetes mellitus. Ann Pharmacother 2005;39:102-109.
15. Hauner H: The new concept of adipose tissue function. Physiol Behav 2004;83:653-658.
16. Hauner H: Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 2005;64:163-169.
17. Wang MY, Grayburn P, Chen S, et al.: Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc Natl Acad Sci USA 2008;105:6139-6144.
18. Slawik M, Vidal-Puig AJ: Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev 2006;5:144-164.
19. Guilherme A, Virbasius JV, Puri V, Czech MP: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:367-377.
20. Turner RC, Cull CA, Frighi V, Holman RR: Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes study (UKPDS) Group. JAMA 1999;281:2005-2012.
21. Krentz AJ, Bailey CJ: Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005;65:385-411.
22. Xu ME, Xiao SZ, Sun YH, et al.: A preadipocyte differentiation assay as a method for screening potential anti-type II diabetes drugs from herbal extracts. Planta Med 2006;72:14-19.
23. Kasturi R, Joshi VC: Hormonal regulation of stearoyl Coenzyme A desaturase activity and lipogenesis during adipose conversion of 3T3-l1 cells. J Biol Chem 1982;257:12224-12230.
24. Guide for the Care and Use of Laboratory Animals. National Academies Press, Washington, DC, 1996.
25. Langin D, Arner P: Importance of TNFalpha and neutral lipases in human adipose tissue lipolysis. Trends Endocrinol Metab 2006;17:314-320.
26. Okuno A, Tamemoto H, Tobe K, et al.: Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998;101: 1354-1361.
27. Olefsky JM: Mechanisms of decreased insulin responsiveness of large adipocytes. Endocrinology 1977;100:1169-1177.
28. Smith J, Al-Amri M, Dorairaj P, Sniderman A: The adipocyte life cycle hypothesis. Clin Sci (Lond) 2006;110:1-9.
29. Martin G, Schoonjans K, Staels B, Auwerx J: PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. Atherosclerosis 1998;137(Suppl):S75-S80.
30. Thompson LU, Yoon JH, Jenkins DJ, Wolever TM, Jenkins AL: Relationship between polyphenol intake and blood glucose response of normal and diabetic individuals. Am J Clin Nutr 1984;39:745-751.
31. Villegas R, Gao YT, Yang G, et al.: Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr 2008;87:162-167.
32. Campbell IW, Howlett HC: Worldwide experience of metformin as an effective glucose-lowering agent: a meta-analysis. Diabetes Metab Rev 1995;1(Suppl 1):S57-S62.
33. Leach MJ: Gymnema sylvestre for diabetes mellitus: a systematic review. J Altern Complement Med 2007;13:977-983.
34. Pastore RL, Fratellone P: Potential health benefits of green tea (Camellia sinensis): a narrative review. Explore (NY) 2006;2: 531-539.
35. Huang TH, Peng G, Kota BP, et al.: Anti-diabetic action of Punica granatum flower extract: activation of PPAR-gamma and identification of an active component. Toxicol Appl Pharmacol 2005;207:160-169.
36. Vuksan V, Sievenpiper JL: Herbal remedies in the management of diabetes: lessons learned from the study of ginseng. Nutr Metab Cardiovasc Dis 2005;15:149-160.
37. Shimura M, Hasumi A, Minato T, et al.: Isohumulones modulate blood lipid status through the activation of PPAR alpha. Biochim Biophys Acta 2005;1736:51-60.
38. Yajima H, Ikeshima E, Shiraki M, et al.: Isohumulones, bitter acids derived from hops, activate both peroxisome proliferatoractivated receptor alpha and gamma and reduce insulin resistance. J Biol Chem 2004;279:33456-33462.
39. Yang JY, Della-Fera MA, Rayalam S, Baile CA: Effect of xanthohumol and isoxanthohumol on 3T3-l1 cell apoptosis and adipogenesis. Apoptosis 2007;12:1953-1963.
40. Nozawa H: Xanthohumol, the chalcone from beer hops (Humulus lupulus l.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-a(y) mice. Biochem Biophys Res Commun 2005;336:754-761.
41. Bowers WS, Nishino C, Montgomery ME, Nault LR, Nielson MW: Sesquiterpene progenitor, germacrene a: an alarm pheromone in aphids. Science 1977;196:680-681.
42. Cawthorn WP, Sethi JK: TNF-alpha and adipocyte biology. FEBS Lett 2008;582:117-131.
43. Bajaj M, Suraamornkul S, Romanelli A, et al.: Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 2005;54:3148-3153.
44. Roffey B, Atwal A, Kubow S: Cinnamon water extracts increase glucose uptake but inhibit adiponectin secretion in 3t3-l1 adipose cells. Mol Nutr Food Res 2006;50:739-745.
45. Rao TP, Sakaguchi N, Juneja LR, Wada E, Yokozawa T: Amla (Emblica officinalis Gaertn.) extracts reduce oxidative stress in streptozotocin-induced diabetic rats. J Med Food 2005;8:362-368.
46. Ali MM, Agha FG: Amelioration of streptozotocin-induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene. Scand J Clin Lab Invest 2009;69:371-379.
47. Ford ES, Mokdad AH, Giles WH, Brown DW: The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346-2352.
48. Suzuki K, Ito Y, Nakamura S, Ochiai J, Aoki K: Relationship between serum carotenoids and hyperglycemia: a populationbased cross-sectional study. J Epidemiol 2002;12:357-366.
49. Howlett HCS, Bailey CJ: 1. Galegine and antidiabetic plants. In: Metformin: The Gold Standard (Bailey CJ, Campbell IW, Chan JCN, Davidson JA, Howlett HCS, Ritz P, eds.). John Wiley & Sons, Chichester, UK, 2007, pp. 3-9.